{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:22:20Z","timestamp":1789539740868,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.atherosclerosis.2017.08.013","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T02:30:22Z","timestamp":1503282622000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II"],"prefix":"10.1016","volume":"266","author":[{"given":"Anselm K.","family":"Gitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ferri\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Horack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Almahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Keong","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishali","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.atherosclerosis.2017.08.013_bib1","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1177\/1010539510373034","article-title":"Cardiovascular disease in the Asia Middle East region: global trends and local implications","volume":"22","author":"Ramahi","year":"2010","journal-title":"Asia Pac J. Public Health"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.08.013_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1540-8183.2007.00298.x","article-title":"Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention","volume":"20","author":"Kumar","year":"2007","journal-title":"J.\u00a0Interv. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.08.013_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/eci.12255","article-title":"Update on the efficacy of statin treatment in acute coronary syndromes","volume":"44","author":"Rosa","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.08.013_bib4","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2014.02.034","article-title":"Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"113","author":"Navarese","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2017.08.013_bib5","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehl125","article-title":"Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes","volume":"27","author":"Lenderink","year":"2006","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.08.013_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.amjcard.2007.04.023","article-title":"Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein >or=100 mg\/dl versus <100 mg\/dl","volume":"100","author":"Spencer","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2017.08.013_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/hrt.2010.201574","article-title":"Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register","volume":"96","author":"Danchin","year":"2010","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.08.013_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"European Association for Cardiovascular Prevention & Rehabilitation","year":"2011","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.08.013_bib9","first-page":"44","article-title":"Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS)","volume":"50","author":"Viigimaa","year":"2014","journal-title":"Med. Kaunas."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.08.013_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ijcp.12315","article-title":"Prevalence of persistent lipid abnormalities in statin-treated patients: belgian results of the Dyslipidaemia International Study (DYSIS)","volume":"68","author":"Devroey","year":"2014","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.08.013_bib11","doi-asserted-by":"crossref","first-page":"e84350","DOI":"10.1371\/journal.pone.0084350","article-title":"Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment","volume":"9","author":"Al Sifri","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.08.013_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5830\/CVJA-2013-071","article-title":"Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)","volume":"24","author":"Raal","year":"2013","journal-title":"Cardiovasc J. Afr."},{"key":"10.1016\/j.atherosclerosis.2017.08.013_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2016.01.018","article-title":"Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries - findings from the EUROASPIRE IV survey","volume":"246","author":"Reiner","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.08.013_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.08.013_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A\u00a0systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J.\u00a0Clin. Pharm. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.08.013_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.09.004","article-title":"Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients","volume":"255","author":"Gitt","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.08.013_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5551\/jat.31179","article-title":"Suboptimal control of lipid levels: results from 29 countries participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS)","volume":"23","author":"Chiang","year":"2016","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2017.08.013_bib18","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9493","key":"10.1016\/j.atherosclerosis.2017.08.013_bib19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.08.013_bib20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ijcard.2012.04.066","article-title":"Adherence to ACC\/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics","volume":"167","author":"Longenecker","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.08.013_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0003319710394163","article-title":"Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events","volume":"62","author":"Al-Zakwani","year":"2011","journal-title":"Angiology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.08.013_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00392-013-0581-2","article-title":"Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study","volume":"102","author":"Liosis","year":"2013","journal-title":"Clin. Res. Cardiol."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2017.08.013_bib23","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.08.013_bib24","first-page":"655","article-title":"Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA\/KORA Myocardial Infarction Registry","volume":"103","author":"Amann","year":"2014","journal-title":"Clin. Res. Cardiol."},{"issue":"50","key":"10.1016\/j.atherosclerosis.2017.08.013_bib25","first-page":"856","article-title":"Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis","volume":"108","author":"Mangiapane","year":"2011","journal-title":"Dtsch. Arztebl Int."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2017.08.013_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00059-014-4161-7","article-title":"Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany","volume":"40","author":"Zeymer","year":"2015","journal-title":"Herz"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.08.013_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ehjcvp\/pvw006","article-title":"Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER","volume":"2","author":"Karlson","year":"2016","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2017.08.013_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.08.013_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.08.013_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.08.013_bib31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.08.013_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1741826711400545","article-title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","volume":"19","author":"Gitt","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.08.013_bib33","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.08.013_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.08.013_bib35","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.08.013_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/clc.22583","article-title":"Residual ischemic risk and its determinants in patients with previous myocardial infarction and without prior stroke or TIA: insights from the REACH registry","volume":"39","author":"Abtan","year":"2016","journal-title":"Clin. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017312352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017312352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T07:27:36Z","timestamp":1535441256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017312352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"alternative-id":["S0021915017312352"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.08.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}